Gardiner Nancy B boosted its position in CVS Health Corporation (NYSE:CVS) by 2.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 18,954 shares of the pharmacy operator’s stock after buying an additional 509 shares during the quarter. CVS Health Corporation makes up about 3.4% of Gardiner Nancy B’s holdings, making the stock its 9th biggest position. Gardiner Nancy B’s holdings in CVS Health Corporation were worth $1,489,000 at the end of the most recent reporting period.
A number of other large investors have also recently bought and sold shares of CVS. CGOV Asset Management grew its stake in CVS Health Corporation by 0.3% in the 1st quarter. CGOV Asset Management now owns 1,148,337 shares of the pharmacy operator’s stock valued at $120,090,000 after buying an additional 3,466 shares during the last quarter. Alta Capital Management LLC grew its stake in CVS Health Corporation by 154.7% in the 1st quarter. Alta Capital Management LLC now owns 550,646 shares of the pharmacy operator’s stock valued at $43,225,000 after buying an additional 334,438 shares during the last quarter. Quotient Investors LLC grew its stake in CVS Health Corporation by 5.7% in the 1st quarter. Quotient Investors LLC now owns 3,700 shares of the pharmacy operator’s stock valued at $290,000 after buying an additional 200 shares during the last quarter. Ledyard National Bank grew its stake in CVS Health Corporation by 82.2% in the 1st quarter. Ledyard National Bank now owns 80,951 shares of the pharmacy operator’s stock valued at $6,355,000 after buying an additional 36,515 shares during the last quarter. Finally, Bollard Group LLC grew its stake in CVS Health Corporation by 11.3% in the 1st quarter. Bollard Group LLC now owns 19,390 shares of the pharmacy operator’s stock valued at $1,522,000 after buying an additional 1,976 shares during the last quarter. Institutional investors and hedge funds own 81.55% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was posted by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another website, it was stolen and republished in violation of U.S. & international copyright laws. The correct version of this news story can be read at https://www.themarketsdaily.com/2017/09/12/cvs-health-corporation-cvs-shares-bought-by-gardiner-nancy-b.html.
In other CVS Health Corporation news, EVP Helena Foulkes sold 20,332 shares of the stock in a transaction dated Monday, June 19th. The shares were sold at an average price of $76.98, for a total transaction of $1,565,157.36. Following the sale, the executive vice president now directly owns 59,300 shares in the company, valued at $4,564,914. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Richard J. Swift sold 2,500 shares of the stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $79.62, for a total transaction of $199,050.00. Following the sale, the director now owns 3,258 shares in the company, valued at $259,401.96. The disclosure for this sale can be found here. Insiders sold 43,165 shares of company stock worth $3,390,847 over the last 90 days. 0.61% of the stock is currently owned by corporate insiders.
A number of research analysts recently issued reports on the stock. Needham & Company LLC reiterated a “hold” rating on shares of CVS Health Corporation in a research note on Sunday. BidaskClub lowered shares of CVS Health Corporation from a “hold” rating to a “sell” rating in a research note on Friday, August 25th. Loop Capital assumed coverage on shares of CVS Health Corporation in a research note on Thursday, August 24th. They issued a “hold” rating and a $83.00 target price on the stock. Citigroup Inc. lowered their target price on shares of CVS Health Corporation from $88.00 to $87.00 and set a “neutral” rating on the stock in a research note on Thursday, August 17th. Finally, Robert W. Baird reiterated an “outperform” rating and issued a $90.00 target price on shares of CVS Health Corporation in a research note on Monday, August 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have given a buy rating to the company’s stock. CVS Health Corporation currently has a consensus rating of “Buy” and an average price target of $90.83.
CVS Health Corporation (NYSE CVS) traded up 2.63% during trading on Tuesday, hitting $81.82. 2,761,238 shares of the stock were exchanged. The stock has a market capitalization of $83.18 billion, a price-to-earnings ratio of 16.30 and a beta of 0.92. CVS Health Corporation has a 52 week low of $69.30 and a 52 week high of $91.82. The firm has a 50-day moving average of $78.37 and a 200-day moving average of $78.89.
CVS Health Corporation (NYSE:CVS) last released its quarterly earnings results on Tuesday, August 8th. The pharmacy operator reported $1.33 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.31 by $0.02. CVS Health Corporation had a net margin of 2.93% and a return on equity of 17.47%. The business had revenue of $45.69 billion for the quarter, compared to the consensus estimate of $45.36 billion. During the same period in the prior year, the company posted $1.32 earnings per share. CVS Health Corporation’s revenue was up 4.5% compared to the same quarter last year. Equities research analysts anticipate that CVS Health Corporation will post $5.88 earnings per share for the current fiscal year.
About CVS Health Corporation
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.